Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Stereoselective synthesis of 3‐azido‐2,3‐dideoxy‐D‐ribose derivatives and its utilization for the synthesis of anti‐HIV nucleosides

Identifieur interne : 001C25 ( Istex/Checkpoint ); précédent : 001C24; suivant : 001C26

Stereoselective synthesis of 3‐azido‐2,3‐dideoxy‐D‐ribose derivatives and its utilization for the synthesis of anti‐HIV nucleosides

Auteurs : Lak S. Jeong [États-Unis] ; J. Warren Beach [États-Unis] ; Chung K. Chu [États-Unis]

Source :

RBID : ISTEX:D68404EE2390C11C003FC47045D8E0F864D28EBC

Abstract

Detail account of the synthesis of 3′‐azido nucleosides utilizing 3‐azido‐2,3‐dideoxy‐D‐ribose derivative 7 as the key intermediate was described. The key intermediate 7 was synthesized from D‐mannitol in 8 steps in a preparative scale. The Michael reaction of the azide group with α,β‐unsaturated‐γ‐butyrolactone 4 was affected by the steric bulkiness of the substituent at the 5‐O position. A bulky t‐butyldiphenylsilyl substitution at 5‐O gave almost exclusively the α‐azido adduct 5b, while unsubstitution at 5‐O produced 1:1 mixture of α‐and β‐adducts. The ratio of α to β anomers in the condensation between azido acetate 7a and pyrimidine bases for the preparation of AZT and AZDU was greatly influenced by the solvent and the Lewis acid catalyst used. In the synthesis of 12 (AZDU, CS‐87), the combination of dichloroethane and trimethylsilyl triflate gave an optimal result, while in the case of 14 (AZT), various conditions gave similar ratio of α,β anomers. The azido intermediate 7b was also utilized for the synthesis of several 3′‐azido purine‐like nucleosides 16–27. The glycosylation was also affected by the Lewis acid catalyst. Boron trifluoride etherate gave the desired N1‐glycosylated compounds in which the α‐anomer was major, but other catalysts such as trimethylsilyl triflate or stannic chloride produced N2‐glycosylated compounds as the major products. The newly synthesized purine‐like compounds have been tested against HIV, however, none of them showed any significant activity.

Url:
DOI: 10.1002/jhet.5570300543


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:D68404EE2390C11C003FC47045D8E0F864D28EBC

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Stereoselective synthesis of 3‐azido‐2,3‐dideoxy‐D‐ribose derivatives and its utilization for the synthesis of anti‐HIV nucleosides</title>
<author>
<name sortKey="Jeong, Lak S" sort="Jeong, Lak S" uniqKey="Jeong L" first="Lak S." last="Jeong">Lak S. Jeong</name>
</author>
<author>
<name sortKey="Beach, J Warren" sort="Beach, J Warren" uniqKey="Beach J" first="J. Warren" last="Beach">J. Warren Beach</name>
</author>
<author>
<name sortKey="Chu, Chung K" sort="Chu, Chung K" uniqKey="Chu C" first="Chung K." last="Chu">Chung K. Chu</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:D68404EE2390C11C003FC47045D8E0F864D28EBC</idno>
<date when="1993" year="1993">1993</date>
<idno type="doi">10.1002/jhet.5570300543</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-D7VW70RN-0/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001B74</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001B74</idno>
<idno type="wicri:Area/Istex/Curation">001B74</idno>
<idno type="wicri:Area/Istex/Checkpoint">001C25</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001C25</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Stereoselective synthesis of 3‐azido‐2,3‐dideoxy‐D‐ribose derivatives and its utilization for the synthesis of anti‐HIV nucleosides</title>
<author>
<name sortKey="Jeong, Lak S" sort="Jeong, Lak S" uniqKey="Jeong L" first="Lak S." last="Jeong">Lak S. Jeong</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Géorgie (États-Unis)</region>
</placeName>
<wicri:cityArea>Department of Medicinal Chemistry, College of Pharmacy, The University of Georgia, Athens</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Beach, J Warren" sort="Beach, J Warren" uniqKey="Beach J" first="J. Warren" last="Beach">J. Warren Beach</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Géorgie (États-Unis)</region>
</placeName>
<wicri:cityArea>Department of Medicinal Chemistry, College of Pharmacy, The University of Georgia, Athens</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Chu, Chung K" sort="Chu, Chung K" uniqKey="Chu C" first="Chung K." last="Chu">Chung K. Chu</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Géorgie (États-Unis)</region>
</placeName>
<wicri:cityArea>Department of Medicinal Chemistry, College of Pharmacy, The University of Georgia, Athens</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Journal of Heterocyclic Chemistry</title>
<title level="j" type="alt">JOURNAL OF HETEROCYCLIC CHEMISTRY</title>
<idno type="ISSN">0022-152X</idno>
<idno type="eISSN">1943-5193</idno>
<imprint>
<biblScope unit="vol">30</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="1445">1445</biblScope>
<biblScope unit="page" to="1452">1452</biblScope>
<biblScope unit="page-count">8</biblScope>
<publisher>Wiley‐Blackwell</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1993-10">1993-10</date>
</imprint>
<idno type="ISSN">0022-152X</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0022-152X</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Detail account of the synthesis of 3′‐azido nucleosides utilizing 3‐azido‐2,3‐dideoxy‐D‐ribose derivative 7 as the key intermediate was described. The key intermediate 7 was synthesized from D‐mannitol in 8 steps in a preparative scale. The Michael reaction of the azide group with α,β‐unsaturated‐γ‐butyrolactone 4 was affected by the steric bulkiness of the substituent at the 5‐O position. A bulky t‐butyldiphenylsilyl substitution at 5‐O gave almost exclusively the α‐azido adduct 5b, while unsubstitution at 5‐O produced 1:1 mixture of α‐and β‐adducts. The ratio of α to β anomers in the condensation between azido acetate 7a and pyrimidine bases for the preparation of AZT and AZDU was greatly influenced by the solvent and the Lewis acid catalyst used. In the synthesis of 12 (AZDU, CS‐87), the combination of dichloroethane and trimethylsilyl triflate gave an optimal result, while in the case of 14 (AZT), various conditions gave similar ratio of α,β anomers. The azido intermediate 7b was also utilized for the synthesis of several 3′‐azido purine‐like nucleosides 16–27. The glycosylation was also affected by the Lewis acid catalyst. Boron trifluoride etherate gave the desired N1‐glycosylated compounds in which the α‐anomer was major, but other catalysts such as trimethylsilyl triflate or stannic chloride produced N2‐glycosylated compounds as the major products. The newly synthesized purine‐like compounds have been tested against HIV, however, none of them showed any significant activity.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Géorgie (États-Unis)</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Géorgie (États-Unis)">
<name sortKey="Jeong, Lak S" sort="Jeong, Lak S" uniqKey="Jeong L" first="Lak S." last="Jeong">Lak S. Jeong</name>
</region>
<name sortKey="Beach, J Warren" sort="Beach, J Warren" uniqKey="Beach J" first="J. Warren" last="Beach">J. Warren Beach</name>
<name sortKey="Chu, Chung K" sort="Chu, Chung K" uniqKey="Chu C" first="Chung K." last="Chu">Chung K. Chu</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Istex/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C25 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd -nk 001C25 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    RBID
   |clé=     ISTEX:D68404EE2390C11C003FC47045D8E0F864D28EBC
   |texte=   Stereoselective synthesis of 3‐azido‐2,3‐dideoxy‐D‐ribose derivatives and its utilization for the synthesis of anti‐HIV nucleosides
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021